Company: Shire Pharmaceuticals Ltd. Legal category: Prescription. Hospital. Sport permitted. Active ingredient: Icatibant 30mg. Description: Solution for injection. Presentation: 3ml-1, pre-filled syringe. Price on request. Indication: Symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults (with C1-esterase-inhibitor deficiency). Pharmacology: Icatibant is a selective competitive antagonist of the bradykinin type 2 (B2) receptor. It [...]
Pantoloc Control
Company: Novartis Consumer Health. Legal category: OTC. Sport permitted. Active ingredient: Pantoprazole (as Na+ sesquihydrate) 20mg. Description: Yellow, oval, biconvex film-coated tablets imprinted with P20 on one side. Presentation: 20mg-7, €7.79; 20mg-14, €13.49. Indication: Short-term treatment of reflux symptoms. Pharmacology: Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach [...]
Simcovas
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Simvastatin 10mg, 20mg, 40mg. Description: Peach, tan or brick-red-coloured, oval, biconvex, film-coated tablets, scored on one side, resp. Can be divided into equal halves. Presentation: 10mg-28, €7.77; 20mg-28, €13.22; 40mg-28, €13.22. Indications: Treatment of primary hypercholesterolaemia (HC) or mixed dyslipidaemia, as an adjunct [...]
Simvastatin
Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Simvastatin 10mg, 20mg, 40mg. Description: Light pink, pink or dark pink, lenticular, film-coated tablets respectively. 20mg, 40mg: Scored with breakline on one side, can be divided into equal halves only on doctor’s instructions. Not to be broken by hand. Presentation: 10mg-28, €12.40; 20mg-28, [...]
TRUEresult test strips
Company: Clonmel Healthcare. Legal category: GMS. Presentation: 50, €17.03. Clonmel Healthcare are delighted to announce the launch of the new TRUEresult blood glucose test strips which can be used with the new TRUEresult and TRUEresult Twist blood glucose meters which will be replacing the TrueTrack meter. The new TRUEresult and TRUEresult Twist systems offer advanced [...]
MIMS Ireland – change in pricing policy
The editorial team wishes to inform you of a change in pricing policy in MIMS Ireland. Hospital-only products and products on the High-Tech scheme will now be listed at the Price To Wholesalers as per the current pricing policy for GMS reimbursed products. Products which do not fall into these categories will continue to be [...]
Irish Sports Council’s Therapeutic Use Exemption (TUE) Committee Policy on Glucocorticosteroid Injections for Hayfever
Kenalog (triamcinolone) and Depo-medrone (methyl-prednisolone) Intra-muscular Injections for hayfever are prohibited in sport and therefore require a TUE. Kenalog Injection has been discontinued on the Irish market recently but there may still be small quantities of this product available on pharmacy shelves. There are some new hayfever products on the market which are permitted in [...]
Yasmin (ethinylestradiol 30µg + drospirenone) – Update on risk of venous thromboembolism
Recently published studies suggest that the risk of venous thromboembolism (VTE) in association with the use of the combined oral contraceptive Yasmin may be slightly higher than previously estimated, and fall somewhere between the risk associated with combined oral contraceptives (COCs) containing levonorgestrel (otherwise known as ‘second generation’) and those containing desogestrel or gestodene (known [...]
AstraZeneca discontinuations
AstraZeneca wished to notify you that they are planning to withdraw the following products from the Irish market: – Xylocaine 4% w/v topical mucosal solution; 30ml – Bricanyl Respules 5mg/2ml nebuliser solution; 2ml-pack of 20 – Diprivan 1% injection 20ml ampoule-pack of 5 – Losec 40mg powder for solution for infusion Should you require any [...]
By-Madol SR 150mg & 200mg prolonged-release hard capsules discontinuation
Ergha Healthcare Ltd wishes to notify you of their intention to discontinue supply for sale of By-Madol SR 150mg & 200mg prolonged-release hard capsules in Ireland after the 31st of July 2010. All products of these strengths currently on the market will expire at the end of July 2010. This cessation does not affect the [...]